| Chemical identity | Confirms that the material supplied is calcium alpha-ketoglutarate rather than free alpha-ketoglutaric acid or another calcium salt. | Commonly identified as calcium 2-oxoglutarate; one reported anhydrous formula is C10H10CaO10, with a calculated molecular mass of approximately 330.26 g/mol. The exact hydrate or salt form must be stated. | Certificate of Analysis (CoA), product specification, identity test, and a clear statement of salt or hydrate form. |
| Assay and purity | A consistent assay supports accurate formulation, labeling, and batch-to-batch performance. | Use a buyer-approved assay specification, commonly expressed as calcium AKG content on an as-is or dry basis. The test method and calculation basis must be stated because different methods can produce non-comparable results. | Lot-specific CoA, validated or verified analytical method, chromatogram or laboratory worksheet, and independent test results for qualification batches. |
| Elemental calcium content | Helps confirm the salt stoichiometry and prevents confusion between calcium AKG and other AKG forms. | For the anhydrous formula C10H10CaO10, the theoretical calcium contribution is approximately 12.1% by mass. Actual specifications may differ for hydrates or mixtures. | Calcium assay by a suitable validated technique, such as ICP-OES or another documented compendial or validated method. |
| Moisture and loss on drying | Moisture can affect powder flow, stability, net active content, and storage performance. | Set a product-specific limit, commonly reported as loss on drying or water content. The specification should identify the test temperature, duration, and whether the material is a hydrate. | CoA with the numerical result and method reference; retain sample testing under the stated storage conditions. |
| Heavy metals and elemental impurities | Contamination may originate from raw materials, processing equipment, water, or packaging. | Limits should be risk-based and aligned with the intended market and dosage. USP <232>/<233> and ICH Q3D provide recognized frameworks for elemental impurity assessment; there is no single universal limit for every application. | ICP-MS or ICP-OES report covering relevant elements, including lead, arsenic, cadmium, and mercury, plus a documented risk assessment. |
| Microbiological quality | Bulk powders can be exposed to environmental microorganisms during manufacturing, handling, and filling. | Acceptance criteria depend on whether the product is intended for food, dietary supplement, cosmetic, or pharmaceutical use. Total aerobic microbial count, total yeast and mold count, and specified pathogens should be defined for the intended category. | Lot-specific microbiological report using recognized methods, with testing for relevant pathogens such as Salmonella and Escherichia coli where applicable. |
| Residual solvents | Residual processing solvents may affect safety, regulatory compliance, and product odor. | If solvents are used, limits should follow ICH Q3C or the applicable local regulatory framework. If no organic solvents are used, this should be supported by a manufacturing declaration and risk assessment. | Residual-solvent test report, process statement, and documented solvent-control procedure. |
| Particle size and powder performance | Particle size affects blending uniformity, dissolution or dispersion, dust generation, and filling efficiency. | Particle-size limits should be selected according to the application, such as a defined percentage passing through a specified sieve or a laser-diffraction distribution. No single particle-size profile is suitable for every formulation. | Particle-size distribution report, sieve or laser-diffraction method, bulk density, tapped density, and flowability data where relevant. |
| Manufacturing controls | Effective controls reduce the risk of mix-ups, contamination, incorrect labeling, and inconsistent processing. | Look for a documented quality system appropriate to the product category, such as GMP, HACCP, or an ISO 22000-based food-safety system. Certification scope and validity must be checked. | Current certificate, audit summary, site information, change-control procedure, deviation and CAPA records, and allergen or cross-contamination controls. |
| Traceability and batch documentation | Traceability enables targeted recalls, complaint investigation, and verification of raw-material and finished-product history. | Each batch should have a unique lot number linked to raw materials, production records, test results, packaging records, and release authorization. | Batch manufacturing record, lot-specific CoA, certificate of origin where required, retention-sample policy, and recall procedure. |
| Packaging and storage | Calcium AKG powder should be protected from moisture, contamination, and unsuitable temperature conditions during storage and transport. | Packaging configuration, liner material, storage temperature, humidity guidance, and shelf life must be supported by stability or controlled storage data. Common bulk formats may include lined fiber drums or bags, but the actual format must be specified. | Packaging specification, label sample, storage instructions, shelf-life statement, seal-integrity controls, and transport-condition requirements. |
| Regulatory and intended-use fit | A material acceptable for one market or product category may not meet the requirements of another. | Confirm the destination country, product category, permitted claims, labeling rules, contaminant limits, and whether the material is intended for food, dietary supplement, cosmetic, or pharmaceutical use. | Regulatory questionnaire, specification approval, applicable compliance statements, safety data sheet, and market-specific documentation. |
| Commercial consistency | The lowest quoted price may create higher costs if quality varies, shipments are delayed, or re-testing is required. | Compare total cost using the same assay basis, packaging format, Incoterm, freight assumptions, documentation package, minimum order quantity, lead time, and payment terms. | Formal quotation, production capacity statement, historical lead-time records, sample approval results, and written quality agreement. |